WeChat Mini Program
Old Version Features

Functional Immune Responses Against SARS-CoV-2 Variants of Concern after Fourth COVID-19 Vaccine Dose or Infection in Patients with Blood Cancer.

Annika Fendler,Scott T. C. Shepherd,Lewis Au,Mary Wu,Ruth Harvey,Katalin A. Wilkinson,Andreas M. Schmitt,Zayd Tippu,Benjamin Shum,Sheima Farag,Aljosja Rogiers,Eleanor Carlyle,Kim Edmonds,Lyra Del Rosario,Karla Lingard,Mary Mangwende,Lucy Holt,Hamid Ahmod,Justine Korteweg,Tara Foley,Taja Barber,Andrea Emslie-Henry,Niamh Caulfield-Lynch,Fiona Byrne,Daqi Deng,Svend Kjaer,Ok-Ryul Song,Christophe J. Queval,Caitlin Kavanagh,Emma C. Wall,Edward J. Carr,Simon Caidan,Mike Gavrielides,James MacRae,Gavin Kelly,Kema Peat,Denise Kelly,Aida Murra,Kayleigh Kelly,Molly O'Flaherty,Robyn L. Shea,Gail Gardner,Darren Murray,Sanjay Popat,Nadia Yousaf,Shaman Jhanji,Kate Tatham,David Cunningham,Nicholas Van As,Kate Young,Andrew J. S. Furness,Lisa Pickering,Rupert Beale,Charles Swanton,Sonia Gandhi,Steve Gamblin,David L. Bauer,George Kassiotis,Michael Howell,Emma Nicholson,Susanna Walker,Robert J. Wilkinson,James Larkin,Samra Turajlic

Cell Reports Medicine（2022）

Cited 18|Views38
Key words
COVID-19,SARS-CoV-2,blood cancer,variants of concern,neutralizing antibodies,T cells
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined